Tumor infiltrating lymphocytes in malignant melanoma - allies or foes?

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15110%2F20%3A73597500" target="_blank" >RIV/61989592:15110/20:73597500 - isvavai.cz</a>
Alternative codes found
RIV/00098892:_____/20:N0000150 RIV/00843989:_____/20:E0108406
Result on the web
<a href="https://biomed.papers.upol.cz/pdfs/bio/2020/01/04.pdf" target="_blank" >https://biomed.papers.upol.cz/pdfs/bio/2020/01/04.pdf</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.5507/bp.2019.048" target="_blank" >10.5507/bp.2019.048</a>

Result language
angličtina
Original language name
Tumor infiltrating lymphocytes in malignant melanoma - allies or foes?
Original language description
This is an overview of current problematics regarding the role of tumor infiltrating lymphocytes (TILs) in malignant melanomas. Various and often conflicting data have been published, correlating tumor type, stage, prognosis, as well as sex and age of patients. This is partly due to heterogeneity in scaling systems and unstandardized TILs grading but also due to changes of tumor-host interactions. Melanomas are an immunologically heterogeneous group with variability of TILs, where distinct gene expression patterns were found in tumors with absent, and/or non-brisk TIL grade versus brisk TIL grade.
Czech name
—
Czech description
—

Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30109 - Pathology

Publication year
2020
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)